Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.

Postler TS, Desrosiers RC.

J Virol. 2013 Jan;87(1):2-15. doi: 10.1128/JVI.02053-12. Review.

2.

The cytoplasmic domain of the HIV-1 glycoprotein gp41 induces NF-κB activation through TGF-β-activated kinase 1.

Postler TS, Desrosiers RC.

Cell Host Microbe. 2012 Feb 16;11(2):181-93. doi: 10.1016/j.chom.2011.12.005.

4.
5.

The frantic play of the concealed HIV envelope cytoplasmic tail.

Santos da Silva E, Mulinge M, Perez Bercoff D.

Retrovirology. 2013 May 24;10:54. doi: 10.1186/1742-4690-10-54. Review.

6.
7.

Envelope Glycoprotein Internalization Protects Human and Simian Immunodeficiency Virus-Infected Cells from Antibody-Dependent Cell-Mediated Cytotoxicity.

von Bredow B, Arias JF, Heyer LN, Gardner MR, Farzan M, Rakasz EG, Evans DT.

J Virol. 2015 Oct;89(20):10648-55. doi: 10.1128/JVI.01911-15.

8.

Systematic analysis of intracellular trafficking motifs located within the cytoplasmic domain of simian immunodeficiency virus glycoprotein gp41.

Postler TS, Bixby JG, Desrosiers RC, Yuste E.

PLoS One. 2014 Dec 5;9(12):e114753. doi: 10.1371/journal.pone.0114753.

10.

HIV-1 replication.

Freed EO.

Somat Cell Mol Genet. 2001 Nov;26(1-6):13-33. Review.

PMID:
12465460
13.
14.

Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail.

Wyss S, Dimitrov AS, Baribaud F, Edwards TG, Blumenthal R, Hoxie JA.

J Virol. 2005 Oct;79(19):12231-41.

16.
17.

Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.

Chertova E, Bess JW Jr, Crise BJ, Sowder II RC, Schaden TM, Hilburn JM, Hoxie JA, Benveniste RE, Lifson JD, Henderson LE, Arthur LO.

J Virol. 2002 Jun;76(11):5315-25.

18.

A tyrosine-based motif in the HIV-1 envelope glycoprotein tail mediates cell-type- and Rab11-FIP1C-dependent incorporation into virions.

Qi M, Chu H, Chen X, Choi J, Wen X, Hammonds J, Ding L, Hunter E, Spearman P.

Proc Natl Acad Sci U S A. 2015 Jun 16;112(24):7575-80. doi: 10.1073/pnas.1504174112.

19.

HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation.

Checkley MA, Luttge BG, Freed EO.

J Mol Biol. 2011 Jul 22;410(4):582-608. doi: 10.1016/j.jmb.2011.04.042. Review.

20.

HIV-1 escape from the entry-inhibiting effects of a cholesterol-binding compound via cleavage of gp41 by the viral protease.

Waheed AA, Ablan SD, Roser JD, Sowder RC, Schaffner CP, Chertova E, Freed EO.

Proc Natl Acad Sci U S A. 2007 May 15;104(20):8467-71.

Supplemental Content

Support Center